2006Zhongguo Yike Daxue xuebaoRequires access

Clinical significance of determination of serum β_2-microglobulin level in patients with oral tumors

Lu Li

Open publisher page 0 citations

Abstract

Objective: To study the clinical significance of the determination of serum β2-microglobulin(β2-MG) level in patients with oral tumors.Methods: The serum β2-MG level was determined in 39 patients with oral benign tumors and 24 patients with oral malignant tumors.The serum levels of β2-MG before and 1 month after operation were compared in 3 patients with oral malignant tumors.Results: The serum β2-MG level in patients with benign tumors was significantly lower than that in patients with malignant tumors(1.54±0.458 vs.2.09±0.702 mg/L,P 0.05).No significant difference was found in 3 patients before and 1 month after operation(2.11±0.920 vs.1.87±0.383 mg/L, P 0.05).Conclusion: The determination of serum β2-MG level could be used as a supplementary method for the diagnosis of oral tumors.

About this research paper

What this paper is about

Objective: To study the clinical significance of the determination of serum β2-microglobulin(β2-MG) level in patients with oral tumors.Methods: The serum β2-MG level was determined in 39 patients with oral benign tumors and 24 patients with oral malignant tumors.The serum levels of β2-MG before and 1 month after operation were compared in 3 patients with oral malignant tumors.Results: The serum β2-MG level in patients with benign tumors was significantly lower than that in patients with malignant tumors(1.54±0.458 vs.2.09±0.702 mg/L,P 0.05).No significant difference was found in 3 patients before and 1 month after operation(2.11±0.920 vs.1.87±0.383 mg/L, P 0.05).Conclusion: The determination of serum β2-MG level could be used as a supplementary method for the diagnosis of oral tumors.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To study the clinical significance of the determination of serum β2-microglobulin(β2-MG) level in patients with oral tumors.Methods: The serum β2-MG level was determined in 39 patients with oral benign tumors and 24 patients with oral malignant tumors.The serum levels of β2-MG before and 1 month after operation were compared in 3 patients with oral malignant tumors.Results: The serum β2-MG level in patients with benign tumors was significantly lower than that in patients with malignant tumors(1.54±0.458 vs.2.09±0.702 mg/L,P 0.05).No significant difference was found in 3 patients before and 1 month after operation(2.11±0.920 vs.1.87±0.383 mg/L, P 0.05).Conclusion: The determination of serum β2-MG level could be used as a supplementary method for the diagnosis of oral tumors.

Key concepts: Medicine, Clinical significance, Beta-2 microglobulin, Gastroenterology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical significance of determination of serum β_2-microglobulin level in patients with oral tumors — Research Paper | ScholarLens